Takeda GI veteran Parikh takes charge at 'molecular machines' biotech MOMA Therapeutics

After breaking cover last April to go after a whole new class of medicine, Third Rock Ventures' MOMA Therapeutics has grabbed a new chief to take the helm.

Asit Parikh, M.D., Ph.D., joins the ambitious startup as its full-time president and CEO nine months after it got off an $86 million funding round led by VC Third Rock Ventures to systematically go after molecular machines, a family of more than 400 enzymes that others have only stumbled upon by chance.